Liver steatosis and the risk of albuminuria: the multi-ethnic study of atherosclerosis

Journal of Nephrology

Volumn 28, Issue 5, 2015, Pages 577-584

  Shah, Ravi V ^a   Allison, Matthew A ^b   Lima, Joao A C ^c   Abbasi, Siddique A ^d   Mongraw Chaffin, Morgana ^b   Jerosch Herold, Michael ^e   Ding, Jingzhong ^f   Budoff, Matthew J ^g   Murthy, Venkatesh L ^h  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DEPARTMENT OF PATHOLOGY   (United States)

^d BROWN UNIVERSITY   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f WAKE FOREST BAPTIST HEALTH   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Albuminuria; Hepatic steatosis; Inflammation; Obesity

Indexed keywords

C REACTIVE PROTEIN; CREATININE; GELATINASE B; GLUCOSE; INSULIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; STROMELYSIN;

ADULT; AGED; ALBUMINURIA; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY CALCIUM SCORE; DISEASE ASSOCIATION; FATTY LIVER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; URINALYSIS; CLINICAL TRIAL; COMPLICATION; EPIDEMIOLOGY; ETHNIC GROUP; ETHNOLOGY; FOLLOW UP; INCIDENCE; METABOLISM; MULTICENTER STUDY; PHOTOMETRY; PREVALENCE; PROCEDURES; RISK ASSESSMENT; RISK FACTOR; UNITED STATES; X-RAY COMPUTED TOMOGRAPHY;

AGED; ALBUMINURIA; ATHEROSCLEROSIS; CREATININE; ETHNIC GROUPS; FATTY LIVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEPHELOMETRY AND TURBIDIMETRY; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED; UNITED STATES;

EID: 84941204311     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.1007/s40620-015-0177-1     Document Type: Article

References (36)

1. ChandieShaw PK, Berger SP, Mallat M, Frolich M, Dekker FW, Rabelink TJ (2007) Central obesity is an independent risk factor for albuminuria in nondiabetic South Asian subjects. Diabetes Care 30(7):1840–1844
2. Lin WY, Pi-Sunyer FX, Liu CS, Li CI, Davidson LE, Li TC et al (2012) Central obesity and albuminuria: both cross-sectional and longitudinal studies in Chinese. PLoS ONE 7(12):e47960
3. Nam GE, Han K, Park YG, Kim YH, Lee KS, Cho KH et al (2014) Abdominal obesity is associated with albuminuria in women: the 2011 Korea National Health and Nutrition Examination Survey. J Womens Health (Larchmt) 23(3):267–274
4. Mohsen A, Brown R, Hoefield R, Kalra PA, O’Donoghue D, Middleton R et al (2012) Body mass index has no effect on rate of progression of chronic kidney disease in subjects with type 2 diabetes mellitus. J Nephrol 25(3):384–393
5. Briffa JF, McAinch AJ, Poronnik P, Hryciw DH (2013) Adipokines as a link between obesity and chronic kidney disease. Am J Physiol Renal Physiol 305(12):F1629–F1636
6. Targher G, Pichiri I, Zoppini G, Trombetta M, Bonora E (2012) Increased prevalence of chronic kidney disease in patients with Type 1 diabetes and non-alcoholic fatty liver. Diabet Med 29(2):220–226
7. Targher G, Chonchol M, Zoppini G, Abaterusso C, Bonora E (2011) Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: is there a link? J Hepatol 54(5):1020–1029
8. Targher G, Bertolini L, Chonchol M, Rodella S, Zoppini G, Lippi G et al (2010) Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and retinopathy in type 1 diabetic patients. Diabetologia 53(7):1341–1348
9. Targher G, Bertolini L, Rodella S, Zoppini G, Lippi G, Day C et al (2008) Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients. Diabetologia 51(3):444–450
10. Targher G (2006) Visceral adipose tissue may mediate the link between non-alcoholic fatty liver disease and endocrine abnormalities. J Hepatol 45(3):454 author reply-6
11. Targher G, Chonchol M, Bertolini L, Rodella S, Zenari L, Lippi G et al (2008) Increased risk of CKD among type 2 diabetics with nonalcoholic fatty liver disease. J Am Soc Nephrol 19(8):1564–1570
12. Chang Y, Ryu S, Sung E, Woo HY, Oh E, Cha K et al (2008) Nonalcoholic fatty liver disease predicts chronic kidney disease in nonhypertensive and nondiabetic Korean men. Metabolism 57(4):569–576
13. Arase Y, Suzuki F, Kobayashi M, Suzuki Y, Kawamura Y, Matsumoto N et al (2011) The development of chronic kidney disease in Japanese patients with non-alcoholic fatty liver disease. Intern Med 50(10):1081–1087
14. Targher G, Mantovani A, Pichiri I, Mingolla L, Cavalieri V, Mantovani W et al (2014) Nonalcoholic fatty liver disease is independently associated with an increased incidence of chronic kidney disease in patients with type 1 diabetes. Diabetes Care 37(6):1729–1736
15. Foster MC, Hwang SJ, Massaro JM, Hoffmann U, DeBoer IH, Robins SJ et al (2011) Association of subcutaneous and visceral adiposity with albuminuria: the Framingham Heart Study. Obesity (Silver Spring) 19(6):1284–1289
16. Carlsson LM, Romeo S, Jacobson P, Burza MA, Maglio C, Sjoholm K et al (2015) The incidence of albuminuria after bariatric surgery and usual care in Swedish obese subjects (SOS): a prospective controlled intervention trial. Int J Obes (Lond) 39:169–175
17. Bild DE, Bluemke DA, Burke GL, Detrano R, Diez Roux AV, Folsom AR et al (2002) Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol 156(9):871–881
18. Yeboah J, Bertoni AG, Herrington DM, Post WS, Burke GL (2011) Impaired fasting glucose and the risk of incident diabetes mellitus and cardiovascular events in an adult population: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 58(2):140–146
19. Zeb I, Katz R, Nasir K, Ding J, Rezaeian P, Budoff MJ (2013) Relation of nonalcoholic fatty liver disease to the metabolic syndrome: the Multi-Ethnic Study of Atherosclerosis. J Cardiovasc Comput Tomogr. 7(5):311–318
20. Lee SW, Park SH, Kim KW, Choi EK, Shin YM, Kim PN et al (2007) Unenhanced CT for assessment of macrovesicular hepatic steatosis in living liver donors: comparison of visual grading with liver attenuation index. Radiology 244(2):479–485
21. Pickhardt PJ, Park SH, Hahn L, Lee SG, Bae KT, Yu ES (2012) Specificity of unenhanced CT for non-invasive diagnosis of hepatic steatosis: implications for the investigation of the natural history of incidental steatosis. Eur Radiol 22(5):1075–1082
22. Maruzzelli L, Parr AJ, Miraglia R, Tuzzolino F, Luca A (2014) Quantification of hepatic steatosis: a comparison of computed tomography and magnetic resonance indices in candidates for living liver donation. Acad Radiol 21(4):507–513
23. Kodama Y, Ng CS, Wu TT, Ayers GD, Curley SA, Abdalla EK et al (2007) Comparison of CT methods for determining the fat content of the liver. AJR Am J Roentgenol 188(5):1307–1312
24. Allison MA, Bluemke DA, McClelland R, Cushman M, Criqui MH, Polak JF et al (2013) Relation of leptin to left ventricular hypertrophy (from the Multi-Ethnic Study of Atherosclerosis). Am J Cardiol 112(5):726–730
25. Shah RV, Abbasi S, Heydari B, Rickers C, Jacobs DR Jr, Wang L et al (2013) Insulin resistance, subclinical left ventricular remodeling, and the obesity paradox: the Multi-Ethnic Study of Atherosclerosis. J Am Coll Cardiol 61:1698–1706
26. DeFilippis AP, Kramer HJ, Katz R, Wong ND, Bertoni AG, Carr J et al (2010) Association between coronary artery calcification progression and microalbuminuria: the MESA study. JACC Cardiovasc Imaging 3(6):595–604
27. Tison GH, Blaha MJ, Budoff MJ, Katz R, Rivera JJ, Bertoni AG et al (2011) The relationship of insulin resistance and extracoronary calcification in the multi-ethnic study of atherosclerosis. Atherosclerosis 218(2):507–510
28. Garimella PS, Ix JH, Katz R, Shlipak MG, Criqui MH, Siscovick DS et al (2015) Association of albumin-creatinine ratio and cystatin C with change in ankle-brachial index: the multi-ethnic study of atherosclerosis (MESA). Am J Kidney Dis 65:33–40
29. Nieto FJ, Coresh J (1996) Adjusting survival curves for confounders: a review and a new method. Am J Epidemiol 143(10):1059–1068
30. Targher G, Chonchol MB, Byrne CD (2014) CKD and nonalcoholic fatty liver disease. Am J Kidney Dis 64(4):638–652
31. Jenks SJ, Conway BR, Hor TJ, Williamson RM, McLachlan S, Robertson C et al (2014) Hepatic steatosis and non-alcoholic fatty liver disease are not associated with decline in renal function in people with Type 2 diabetes. Diabet Med 31(9):1039–1046
32. Sirota JC, McFann K, Targher G, Chonchol M, Jalal DI (2012) Association between nonalcoholic liver disease and chronic kidney disease: an ultrasound analysis from NHANES 1988–1994. Am J Nephrol 36(5):466–471
33. Yilmaz Y, Alahdab YO, Yonal O, Kurt R, Kedrah AE, Celikel CA et al (2010) Microalbuminuria in nondiabetic patients with nonalcoholic fatty liver disease: association with liver fibrosis. Metabolism 59(9):1327–1330
34. Ricci C, Longo R, Gioulis E, Bosco M, Pollesello P, Masutti F et al (1997) Noninvasive in vivo quantitative assessment of fat content in human liver. J Hepatol 27(1):108–113
35. Limanond P, Raman SS, Lassman C, Sayre J, Ghobrial RM, Busuttil RW et al (2004) Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings. Radiology 230(1):276–280
36. Elsayed EF, Sarnak MJ, Tighiouart H, Griffith JL, Kurth T, Salem DN et al (2008) Waist-to-hip ratio, body mass index, and subsequent kidney disease and death. Am J Kidney Dis 52(1):29–38